Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $262,948 | 165 | 87.6% |
| Food and Beverage | $23,217 | 1,119 | 7.7% |
| Travel and Lodging | $12,467 | 64 | 4.2% |
| Consulting Fee | $1,150 | 2 | 0.4% |
| Education | $406.31 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $108,862 | 233 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $61,500 | 168 | $0 (2023) |
| AbbVie Inc. | $43,979 | 89 | $0 (2023) |
| Depomed, Inc. | $26,858 | 73 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $15,889 | 33 | $0 (2021) |
| Allergan, Inc. | $14,593 | 51 | $0 (2022) |
| Assertio Therapeutics, Inc. | $7,096 | 41 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $6,200 | 48 | $0 (2022) |
| UPSHER-SMITH LABORATORIES LLC | $4,273 | 21 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,592 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $502.47 | 28 | Teva Pharmaceuticals USA, Inc. ($73.60) |
| 2022 | $31,564 | 193 | ABBVIE INC. ($21,177) |
| 2021 | $62,142 | 215 | AbbVie Inc. ($22,705) |
| 2020 | $42,855 | 232 | Amgen Inc. ($18,056) |
| 2019 | $62,727 | 248 | Amgen Inc. ($43,203) |
| 2018 | $65,966 | 222 | Amgen Inc. ($41,085) |
| 2017 | $34,431 | 218 | Depomed, Inc. ($26,858) |
All Payment Transactions
1,356 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROLOGY | ||||||
| 03/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Neuroscience | ||||||
| 03/29/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Central Nervous System | ||||||
| 03/28/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/27/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: NEUROLOGY | ||||||
| 03/22/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: NEUROLOGY | ||||||
| 03/16/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: PAIN | ||||||
| 03/13/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Central Nervous System | ||||||
| 03/06/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neurology | ||||||
| 02/22/2023 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Neurology | ||||||
| 02/21/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Central Nervous System | ||||||
| 02/16/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: PAIN | ||||||
| 02/15/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROLOGY | ||||||
| 02/09/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Musculoskeletal | ||||||
| 02/08/2023 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Parkinson's disease | ||||||
| 02/02/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Neurology | ||||||
| 01/31/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Central Nervous System | ||||||
| 01/18/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: NEUROLOGY | ||||||
| 01/17/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 01/11/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROLOGY | ||||||
| 01/11/2023 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 384 | 710 | $57,351 | $20,128 |
| 2022 | 18 | 1,684 | 9,348 | $516,647 | $246,088 |
| 2021 | 21 | 2,141 | 13,445 | $619,900 | $323,591 |
| 2020 | 24 | 2,483 | 15,610 | $675,322 | $320,142 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 83 | $14,525 | $6,378 | 43.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 38 | 38 | $11,161 | $4,298 | 38.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 25 | 25 | $8,548 | $3,500 | 40.9% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 33 | 36 | $6,918 | $2,252 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $4,250 | $1,509 | 35.5% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 31 | 34 | $6,875 | $1,139 | 16.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 37 | 40 | $2,760 | $544.15 | 19.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 67 | 377 | $1,885 | $301.06 | 16.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 39 | 43 | $430.00 | $206.72 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 656 | $107,625 | $61,373 | 57.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 119 | 227 | $75,790 | $43,181 | 57.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 136 | 273 | $79,064 | $40,011 | 50.6% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 125 | 294 | $56,296 | $21,634 | 38.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 13 | 4,000 | $29,000 | $19,595 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 246 | $28,000 | $16,450 | 58.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 123 | 288 | $58,219 | $10,940 | 18.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 155 | 371 | $25,595 | $7,981 | 31.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 16 | 39 | $7,800 | $4,241 | 54.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $9,250 | $4,164 | 45.0% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2022 | 14 | 43 | $8,350 | $4,000 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $4,000 | $2,224 | 55.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 200 | 2,410 | $12,050 | $2,210 | 18.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 22 | 24 | $3,513 | $2,105 | 59.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 153 | 347 | $3,470 | $1,769 | 51.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 22 | $3,300 | $1,578 | 47.8% |
About Dr. James Cooper, M.D
Dr. James Cooper, M.D is a Neurology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356436745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Cooper, M.D has received a total of $300,188 in payments from pharmaceutical and medical device companies, with $502.47 received in 2023. These payments were reported across 1,356 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($262,948).
As a Medicare-enrolled provider, Cooper has provided services to 6,692 Medicare beneficiaries, totaling 39,113 services with total Medicare billing of $909,950. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Pain Medicine, Neuroradiology
- Location Greenville, NC
- Active Since 10/03/2006
- Last Updated 07/29/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356436745
Products in Payments
- Aimovig (Biological) $108,810
- UBRELVY (Drug) $58,145
- Cambia (Drug) $33,401
- AJOVY (Drug) $30,011
- AJOVY (Biological) $26,638
- NURTEC ODT (Drug) $18,507
- ONZETRA Xsail (Drug) $5,674
- TOSYMRA (Drug) $4,024
- RYTARY (Drug) $848.98
- AUBAGIO (Drug) $759.80
- TROKENDI XR (Drug) $526.84
- NUEDEXTA (Drug) $499.12
- AIMOVIG (Biological) $497.31
- BOTOX (Biological) $276.77
- AUSTEDO (Drug) $272.72
- Neupro (Drug) $254.72
- XTAMPZA (Drug) $231.55
- Nucynta (Drug) $211.26
- Gralise (Drug) $211.18
- KESIMPTA (Drug) $188.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greenville
Mary Hughes, Md, MD
Neurology — Payments: $544,207
Fredy Revilla, M.d, M.D
Neurology — Payments: $251,715
Susan Evans, Md, MD
Neurology — Payments: $214,695
Dr. John Porter, Md, MD
Neurology — Payments: $143,009
Kathleen Woschkolup, Md, MD
Neurology — Payments: $124,535
Dr. Amber Stutz, Md, MD
Neurology — Payments: $50,564